Brightspring Health Services Inc (BTSG)

Brightspring Health Services witnessed significant insider trading activity over the past ninety days, characterized exclusively by divestments. Major shareholders, including KKR entities, alongside key executives, executed substantial sales totaling over 3.4 billion dollars. These transactions occurred following a positive earnings report, while the stock price maintains a position near its annual peak.
Ticker: BTSG Exchange: NSM


Loading...
Purchase Sale Planned purchase Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Upgrade for signal details

Upgrade to see score, net flow, insiders and context.

Upgrade to see full signal details →

Insider trades have triggered activity signals for Brightspring Health Services Inc. Upgrade to see score, net flow, insiders and the full signal context.

Top insiders
Trades
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
1.2
Nalley Lisa A See Remarks Officer
Transaction date
Sale
Price
499.19
Quantity 72,847 -18.5%
Value US$3,005,620
2.3
Phipps Jennifer A Chief Financial Officer Officer
Transaction date
Sale
Price
58.75
Quantity 35,000 -12.3%
Value US$2,056,250
2.3
Phipps Jennifer A Chief Financial Officer Officer
Transaction date
Sale
Price
58.75
Quantity 35,000 -12.3%
Value US$2,056,250
2.4
ROUSSEAU JON B See Remarks Executive Director
Transaction date
Sale
Price
58.75
Quantity 130,000 -100.0%
Value US$7,637,500
2.4
ROUSSEAU JON B See Remarks Executive Director
Transaction date
Sale
Price
58.75
Quantity 130,000 -9.8%
Value US$7,637,500
1.4
Barnes Robert Allen Former Officer Officer
Transaction date
Proposed sale
Price
60.27
Quantity 62,608
Value US$3,773,232
1.4
Barnes Robert Allen Former Officer Officer
Transaction date
Proposed sale
Price
59.95
Quantity 9,201
Value US$551,567
1.2
Nalley Lisa A See Remarks Officer
Transaction date
Sale
Price
41.15
Quantity 30,000 -21.3%
Value US$1,234,500
2.4
ROUSSEAU JON B See Remarks Executive Director
Transaction date
Sale
Price
41.15
Quantity 220,000 -17.7%
Value US$9,053,000
2.3
Phipps Jennifer A Chief Financial Officer Officer
Transaction date
Sale
Price
41.15
Quantity 35,000 -15.1%
Value US$1,440,250
2.4
ROUSSEAU JON B See Remarks Executive Director
Transaction date
Sale
Price
28.78
Quantity 235,000 -17.2%
Value US$6,763,770
1.2
Nalley Lisa A See Remarks Officer
Transaction date
Sale
Price
28.78
Quantity 20,000 -13.2%
Value US$575,640
1.4
McMaude Michael A Former Officer Officer
Transaction date
Proposed sale
Price
22.40
Quantity 16,168
Value US$362,241
1.4
Barnes Robert Allen President, Community Living Officer
Transaction date
Sale
Price
21.75
Quantity 30,730 -43.9%
Value US$668,378
1.2
Nalley Lisa A See Remarks Officer
Transaction date
Sale
Price
21.75
Quantity 14,415 -9.9%
Value US$313,526
1.4
McMaude Michael A See Remarks Officer
Transaction date
Sale
Price
21.75
Quantity 119,298 -36.5%
Value US$2,594,732
2.3
Phipps Jennifer A Chief Accounting Officer Officer
Transaction date
Sale
Price
21.75
Quantity 15,616 -6.4%
Value US$339,648
2.4
ROUSSEAU JON B See Remarks Executive Director
Transaction date
Sale
Price
21.75
Quantity 531,840 -31.0%
Value US$11,567,520
Walgreen Co. 10% Stockholder Large shareholder
Transaction date
Proposed sale
Price
22.15
Quantity 12,000,000
Value US$265,800,000
2.9
Walgreens Boots Alliance, Inc. Large shareholder
Transaction date
Sale
Price
129,330,577.74
Quantity 11,619,998 -33.3%
Value US$1,502,821,054,677,644
2.4
KKR Group Partnership L.P. Large shareholder
Transaction date
Purchase
Price
11.13
Quantity 11,619,998 +14.3%
Value US$129,330,578
2.2
DAmbrosio Matthew Non-Executive Director
Transaction date
Purchase
Price
11.46
Quantity 1,000 +inf%
Value US$11,461
3.3
Yowler Jennifer President, PharMerica Officer
Transaction date
Purchase
Price
8.21
Quantity 3,000 +5.2%
Value US$24,630
3.6
Mattingly James F Jr See Remarks Officer
Transaction date
Purchase
Price
8.26
Quantity 6,080 +4.7%
Value US$50,221
2.4
ROUSSEAU JON B See Remarks Executive Director
Transaction date
Purchase
Price
8.09
Quantity 18,400 +5.2%
Value US$148,856
2.4
ROUSSEAU JON B See Remarks Executive Director
Transaction date
Purchase
Price
8.09
Quantity 18,400 +1.8%
Value US$148,856
2.4
ROUSSEAU JON B See Remarks Executive Director
Transaction date
Purchase
Price
8.12
Quantity 37,405 +1921.2%
Value US$303,729
3.6
Mattingly James F Jr See Remarks Officer
Transaction date
Purchase
Price
8.18
Quantity 12,280 +10.5%
Value US$100,450
2.3
Phipps Jennifer A Chief Accounting Officer Officer
Transaction date
Purchase
Price
8.14
Quantity 12,300 +8.0%
Value US$100,122
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value
Number of shares Price Value Details
2026-06-05 2026-06-05 S Sale

See Remarks

Officer
72,847 -18.5%
499.19
US$3,005,620
72,847 -18.5% 499.19 US$3,005,620
2026-06-05 2026-06-05 S Sale Large shareholder
19,694 -45.1%
133.98
US$3,094,206
19,694 -45.1% 133.98 US$3,094,206
2026-06-05 2026-06-05 S Sale Large shareholder
97,430 -35.1%
10.48
US$2,744,131
97,430 -35.1% 10.48 US$2,744,131
2026-06-05 2026-06-05 S Sale

Chief Financial Officer

Officer
35,000 -12.3%
58.75
US$2,056,250
35,000 -12.3% 58.75 US$2,056,250
2026-06-05 2026-06-05 S Sale

Chief Financial Officer

Officer
35,000 -12.3%
58.75
US$2,056,250
35,000 -12.3% 58.75 US$2,056,250
2026-06-05 2026-06-05 S Sale Large shareholder
14,669,771 -35.1%
58.45
US$857,492,124
14,669,771 -35.1% 58.45 US$857,492,124
2026-06-05 2026-06-05 S Sale Large shareholder
14,669,771 -35.1%
58.45
US$857,492,124
14,669,771 -35.1% 58.45 US$857,492,124
2026-06-05 2026-06-05 S Sale

See Remarks

Executive Director
130,000 -100.0%
58.75
US$7,637,500
130,000 -100.0% 58.75 US$7,637,500
2026-06-05 2026-06-05 S Sale

See Remarks

Executive Director
130,000 -9.8%
58.75
US$7,637,500
130,000 -9.8% 58.75 US$7,637,500
2026-06-03 2026-06-03 PrS Proposed sale

Former Officer

Officer
62,608
60.27
US$3,773,232
62,608 60.27 US$3,773,232
2026-06-02 2026-06-02 PrS Proposed sale

Former Officer

Officer
9,201
59.95
US$551,567
9,201 59.95 US$551,567
2026-03-06 2026-03-04 S Sale

See Remarks

Officer
30,000 -21.3%
41.15
US$1,234,500
30,000 -21.3% 41.15 US$1,234,500
2026-03-06 2026-03-04 S Sale

See Remarks

Executive Director
220,000 -17.7%
41.15
US$9,053,000
220,000 -17.7% 41.15 US$9,053,000
2026-03-06 2026-03-04 S Sale

Chief Financial Officer

Officer
35,000 -15.1%
41.15
US$1,440,250
35,000 -15.1% 41.15 US$1,440,250
2026-03-04 2026-03-04 S Sale Large shareholder
19,715,000 -31.8%
40.96
US$807,546,115
19,715,000 -31.8% 40.96 US$807,546,115
2026-03-04 2026-03-04 S Sale Large shareholder
19,715,000 -31.8%
40.96
US$807,546,115
19,715,000 -31.8% 40.96 US$807,546,115
2025-10-22 2025-10-22 S Sale Large shareholder
14,745,000 -19.1%
28.78
US$424,390,590
14,745,000 -19.1% 28.78 US$424,390,590
2025-10-22 2025-10-22 S Sale Large shareholder
14,745,000 -19.1%
28.78
US$424,390,590
14,745,000 -19.1% 28.78 US$424,390,590
2025-10-22 2025-10-22 S Sale

See Remarks

Executive Director
235,000 -17.2%
28.78
US$6,763,770
235,000 -17.2% 28.78 US$6,763,770
2025-10-22 2025-10-22 S Sale

See Remarks

Officer
20,000 -13.2%
28.78
US$575,640
20,000 -13.2% 28.78 US$575,640
2025-08-14 2025-08-14 PrS Proposed sale

Former Officer

Officer
16,168
22.40
US$362,241
16,168 22.40 US$362,241
2025-06-26 2025-06-24 S Sale Large shareholder
2,100,000 -2.7%
21.15
US$44,418,990
2,100,000 -2.7% 21.15 US$44,418,990
2025-06-26 2025-06-24 S Sale Large shareholder
2,100,000 -2.7%
21.15
US$44,418,990
2,100,000 -2.7% 21.15 US$44,418,990
2025-06-16 2025-06-12 S Sale Large shareholder
13,288,101 -14.3%
21.15
US$281,068,584
13,288,101 -14.3% 21.15 US$281,068,584
2025-06-16 2025-06-12 S Sale Large shareholder
13,288,101 -14.3%
21.15
US$281,068,584
13,288,101 -14.3% 21.15 US$281,068,584
2025-06-13 2025-06-12 S Sale

President, Community Living

Officer
30,730 -43.9%
21.75
US$668,378
30,730 -43.9% 21.75 US$668,378
2025-06-13 2025-06-12 S Sale

See Remarks

Officer
14,415 -9.9%
21.75
US$313,526
14,415 -9.9% 21.75 US$313,526
2025-06-13 2025-06-12 S Sale

See Remarks

Officer
119,298 -36.5%
21.75
US$2,594,732
119,298 -36.5% 21.75 US$2,594,732
2025-06-13 2025-06-12 S Sale

Chief Accounting Officer

Officer
15,616 -6.4%
21.75
US$339,648
15,616 -6.4% 21.75 US$339,648
2025-06-13 2025-06-12 S Sale

See Remarks

Executive Director
531,840 -31.0%
21.75
US$11,567,520
531,840 -31.0% 21.75 US$11,567,520
2025-02-20 2025-02-18 S Sale

Former 10% owner

12,000,000 -51.6%
21.16
US$253,920,000
12,000,000 -51.6% 21.16 US$253,920,000
2025-02-18 2025-02-18 PrS Proposed sale

10% Stockholder

Large shareholder
12,000,000
22.15
US$265,800,000
12,000,000 22.15 US$265,800,000
2024-09-13 2024-09-11 S Sale Large shareholder
11,619,998 -33.3%
129,330,577.74
US$1,502,821,054,677,644
11,619,998 -33.3% 129,330,577.74 US$1,502,821,054,677,644
2024-09-13 2024-09-11 B Purchase Large shareholder
11,619,998 +14.3%
11.13
US$129,330,578
11,619,998 +14.3% 11.13 US$129,330,578
2024-09-13 2024-09-11 B Purchase Large shareholder
11,619,998 +14.3%
11.13
US$129,330,578
11,619,998 +14.3% 11.13 US$129,330,578
2024-05-21 2024-05-20 B Purchase Non-Executive Director
1,000 +inf%
11.46
US$11,461
1,000 +inf% 11.46 US$11,461
2024-03-18 2024-03-15 B Purchase

President, PharMerica

Officer
3,000 +5.2%
8.21
US$24,630
3,000 +5.2% 8.21 US$24,630
2024-03-18 2024-03-15 B Purchase

See Remarks

Officer
6,080 +4.7%
8.26
US$50,221
6,080 +4.7% 8.26 US$50,221
2024-03-18 2024-03-15 B Purchase

See Remarks

Executive Director
18,400 +5.2%
8.09
US$148,856
18,400 +5.2% 8.09 US$148,856
2024-03-18 2024-03-15 B Purchase

See Remarks

Executive Director
18,400 +1.8%
8.09
US$148,856
18,400 +1.8% 8.09 US$148,856
2024-03-15 2024-03-14 B Purchase

See Remarks

Executive Director
37,405 +1921.2%
8.12
US$303,729
37,405 +1921.2% 8.12 US$303,729
2024-03-15 2024-03-14 B Purchase

See Remarks

Officer
12,280 +10.5%
8.18
US$100,450
12,280 +10.5% 8.18 US$100,450
2024-03-15 2024-03-14 B Purchase

Chief Accounting Officer

Officer
12,300 +8.0%
8.14
US$100,122
12,300 +8.0% 8.14 US$100,122